CFL1 and cancer: The role of LIMK/cofilin signalling has been studied in several types of cancers and cancer lines, such as breast cancer [51,52,53], colon cancers [54,55], prostate cancers [56,57], ovarian cancers [58], pancreatic cancers [59], and lung cancers [60,61].